Finance

Lists
HCSG:NASDAQ
Healthcare Services Group Inc
$22.31
-2.32%
(-0.53) 1D
Aug 6, 10:46:00 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HCSG...
Open
$22.48
High
$22.78
Low
$22.31
Mkt. cap
1.53B
Avg. vol.
0.00
Volume
144.67K
P/E ratio
13.00
52-wk high
$25.75
52-wk low
$13.69
EPS
$1.72
Beta
0.81
Shares outstanding
68.63M
No. of employees
36K
Open
$22.48
High
$22.78
Low
$22.31
Mkt. cap
1.53B
Avg. vol.
0.00
Volume
144.67K
P/E ratio
13.00
52-wk high
$25.75
52-wk low
$13.69
EPS
$1.72
Beta
0.81
Shares outstanding
68.63M
No. of employees
36K
News stories
From sources across the web
About Healthcare Services Group Inc
CEO-
Employees36K
Founded1976
HeadquartersBensalem Township, Pennsylvania, United States
SectorService
Websitehcsgcorp.com
Analyst ratings
Based on 4 analysts giving stock ratings to HCSG in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for HCSG in the last 3 months.
Highest
Current $22.31
$30.00 (+34.47%)
Average
$26.00 (+16.54%)
Lowest
$24.00 (+7.58%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean Dodge
BMO Capital
Hold
Reiterated
$24.00
+7.6%
07/22/2026
Ryan Halsted
RBC Capital
Hold
Reiterated
$24.00
+7.6%
07/22/2026
Ryan Daniels
William Blair
Buy
Reiterated
-
-
07/22/2026
A.J. Rice
UBS
Buy
Reiterated
$30.00
+34.5%
07/08/2026
Bill Sutherland
Benchmark Co.
Buy
Maintained
$30.00
+34.5%
04/23/2026
Andrew Wittmann
Robert W. Baird
Hold
Maintained
$23.00
+3.1%
04/23/2026
Last report
Jul 22, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.32 / $0.22
+42.50%beat
Revenue / Est. (USD)
470.81M / 471.29M
-0.10%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
464.34M
466.68M
462.77M
470.81M
Cost of goods sold
367.93M
394.61M
386.93M
396.02M
Cost of revenue
367.93M
394.61M
386.93M
396.02M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
50.54M
46.20M
42.00M
52.58M
Operating expense
50.54M
46.20M
42.00M
52.58M
Total operating expenses
418.47M
440.81M
428.93M
448.60M
Operating income
45.86M
25.88M
33.84M
22.21M
Other non operating income
-
-
-
-
EBT including unusual items
57.31M
28.55M
34.54M
31.00M
EBT excluding unusual items
57.29M
28.38M
34.58M
31.04M
Income tax expense
14.36M
-2.69M
8.48M
8.31M
Effective tax rate
25.05%
-9.43%
24.55%
26.79%
Other operating expenses
-
-
-
-
Net income
42.95M
31.24M
26.06M
22.70M
Net profit margin
9.25%
6.69%
5.63%
4.82%
Earnings per share
0.59
0.44
0.37
0.32
Interest and investment income
11.82M
2.88M
1.11M
9.45M
Interest expense
-393.00K
-374.00K
-365.00K
-619.00K
Net interest expenses
11.43M
2.50M
744.00K
8.83M
Depreciation and amortization charges
-
-
-
-
EBITDA
47.79M
27.74M
35.74M
24.33M
Gain or loss from assets sale
92.00K
169.00K
91.00K
90.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps